Pedro Luiz Serrano Usón

1.4k total citations
59 papers, 584 citations indexed

About

Pedro Luiz Serrano Usón is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pedro Luiz Serrano Usón has authored 59 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 28 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pedro Luiz Serrano Usón's work include Pancreatic and Hepatic Oncology Research (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Pedro Luiz Serrano Usón is often cited by papers focused on Pancreatic and Hepatic Oncology Research (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Pedro Luiz Serrano Usón collaborates with scholars based in Brazil, United States and Italy. Pedro Luiz Serrano Usón's co-authors include Mitesh J. Borad, Tanios Bekaii‐Saab, Daniel H. Ahn, Mohamad Bassam Sonbol, Diogo Diniz Gomes Bugano, Fernando Cotait Maluf, Edna Terezinha Rother, Kabir Mody, Amit Mahipal and Jason S. Starr and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Pedro Luiz Serrano Usón

49 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Luiz Serrano Usón Brazil 14 322 181 149 145 144 59 584
Richard M. Goldberg United States 12 433 1.3× 126 0.7× 103 0.7× 214 1.5× 201 1.4× 33 644
Michele Basso Italy 18 521 1.6× 150 0.8× 292 2.0× 212 1.5× 251 1.7× 47 839
Liming Wang China 15 197 0.6× 252 1.4× 292 2.0× 101 0.7× 121 0.8× 62 663
Vincenzo Dadduzio Italy 18 451 1.4× 196 1.1× 297 2.0× 181 1.2× 258 1.8× 39 834
Eleni Vrettou Greece 15 304 0.9× 93 0.5× 145 1.0× 72 0.5× 113 0.8× 33 562
Imane El Dika United States 13 214 0.7× 81 0.4× 178 1.2× 145 1.0× 109 0.8× 30 573
Hideki Ueno Japan 14 389 1.2× 135 0.7× 160 1.1× 168 1.2× 140 1.0× 44 706
Fanny Le Du France 10 238 0.7× 134 0.7× 105 0.7× 153 1.1× 174 1.2× 30 491
Takumi Irie Japan 17 303 0.9× 189 1.0× 271 1.8× 154 1.1× 90 0.6× 42 674
Emmanuelle Samalin France 16 562 1.7× 201 1.1× 87 0.6× 114 0.8× 353 2.5× 75 827

Countries citing papers authored by Pedro Luiz Serrano Usón

Since Specialization
Citations

This map shows the geographic impact of Pedro Luiz Serrano Usón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Luiz Serrano Usón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Luiz Serrano Usón more than expected).

Fields of papers citing papers by Pedro Luiz Serrano Usón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Luiz Serrano Usón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Luiz Serrano Usón. The network helps show where Pedro Luiz Serrano Usón may publish in the future.

Co-authorship network of co-authors of Pedro Luiz Serrano Usón

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Luiz Serrano Usón. A scholar is included among the top collaborators of Pedro Luiz Serrano Usón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Luiz Serrano Usón. Pedro Luiz Serrano Usón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naqvi, Syed Arsalan Ahmed, Zhaohui Jin, Harry H. Yoon, et al.. (2025). Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis. The Oncologist. 30(8). 2 indexed citations
2.
Fraga, Carlos Alberto de Carvalho, Maithilee Menezes, Carolinne de Sales Marques, et al.. (2025). Periostin-positive stellate cells associated with perineural invasion in pancreatic adenocarcinoma. Molecular and Cellular Endocrinology. 611. 112678–112678.
3.
Mariussi, Miriana, Luís Lima, Breno Boueri Affonso, et al.. (2025). Selective Internal Radiation Therapy Combined with Immune Checkpoint Inhibitors in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Single-Arm Meta-Analysis. Digestive Diseases and Sciences. 70(11). 3937–3952.
4.
Okano, Naohiro, Binbin Zheng-Lin, Pedro Luiz Serrano Usón, et al.. (2025). Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advances. Japanese Journal of Clinical Oncology. 55(7). 675–690.
5.
Borad, Mitesh J., et al.. (2024). Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 16(12). 4766–4769.
6.
7.
8.
Usón, Pedro Luiz Serrano & Mitesh J. Borad. (2023). Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and Beyond. Seminars in Liver Disease. 43(2). 218–225. 2 indexed citations
9.
Usón, Pedro Luiz Serrano, et al.. (2023). Utility of AST to platelet ratio index (APRI) score in predicting post-surgical outcomes in patients with cholangiocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 502–502.
10.
Miller, Max, et al.. (2022). Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). International Journal of Molecular Sciences. 24(1). 577–577. 20 indexed citations
11.
Sonbol, Mohamad Bassam, Rabbia Siddiqi, Pedro Luiz Serrano Usón, et al.. (2022). The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis. The Oncologist. 27(12). 1034–1040. 10 indexed citations
12.
Maluf, Fernando Cotait, Graziela Zibetti Dal Molin, Andréia Cristina de Melo, et al.. (2022). Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting. Frontiers in Oncology. 12. 928560–928560. 7 indexed citations
13.
Usón, Pedro Luiz Serrano, et al.. (2022). Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis. Scientific Reports. 12(1). 13592–13592. 16 indexed citations
14.
Usón, Pedro Luiz Serrano & Raphael L. C. Araújo. (2022). Immunotherapy in biliary tract cancers: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology. 14(8). 1446–1455. 7 indexed citations
15.
Dettino, Aldo Lourenço Abbade, Ariel Galapo Kann, Carlos Dzik, et al.. (2021). Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries. JCO Global Oncology. 7(7). 545–549. 1 indexed citations
16.
Sonbol, Mohamad Bassam, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.. (2020). Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma. JAMA Oncology. 6(12). e204930–e204930. 137 indexed citations
17.
Bogenberger, James M., Amro M. Abdelrahman, Jennifer L. Leiting, et al.. (2020). Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer Chemotherapy and Pharmacology. 85(6). 1063–1078. 12 indexed citations
18.
Usón, Pedro Luiz Serrano, et al.. (2019). Metastatic carcinoma of unknown primary with complete metabolic response following sorafenib-based chemotherapy. SHILAP Revista de lepidopterología. 7. 2050313X19838739–2050313X19838739. 1 indexed citations
19.
Usón, Pedro Luiz Serrano, Edna Terezinha Rother, Fernando Cotait Maluf, & Diogo Diniz Gomes Bugano. (2018). Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer. Clinical Colorectal Cancer. 17(3). 187–197. 20 indexed citations
20.
Usón, Pedro Luiz Serrano, et al.. (2017). Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer. SHILAP Revista de lepidopterología. 10. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard M. Goldberg Breakdown of academic impact, for papers by Michele Basso Breakdown of academic impact, for papers by Liming Wang Breakdown of academic impact, for papers by Vincenzo Dadduzio Breakdown of academic impact, for papers by Eleni Vrettou Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Hideki Ueno Breakdown of academic impact, for papers by Fanny Le Du Breakdown of academic impact, for papers by Takumi Irie Breakdown of academic impact, for papers by Emmanuelle Samalin
Rankless by CCL
2026